GlobeNewswire Inc | Dec 22, 2021 08:00AM EST

December 22, 2021

MARIETTA, Ga., Dec. 22, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (MIMEDX or the Company), a transformational placental biologics company, today announced that Timothy R. Wright, Chief Executive Officer, and Peter M. Carlson, Chief Financial Officer, will present during the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12 at 5:15 PM EST. Institutional investors interested in a virtual meeting with management during the conference may reach out to their J.P. Morgan representative.

Investors and other interested parties may access the live webcast on the Events page of the Investors section of the Companys website or by clicking here. A replay of the webcast will be available for 30 days on the Companys website at www.mimedx.com following the conclusion of the presentation.

About MIMEDXMIMEDX is a transformational placental biologics company, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental tissue engineering, we have both a commercial business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. MIMEDX has supplied over two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.

Contact:Jack HowarthInvestor Relations404-360-5681jhowarth@mimedx.com

Contact:Hilary DixonCorporate & Strategic Communications404-323-4779hdixon@mimedx.com